Myocardial Strain in the Assessment of Patients With Heart Failure: A Review

Thomas H Marwick1, Sanjiv J Shah2,3, James D Thomas2

  • 1Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

JAMA Cardiology
|February 28, 2019
PubMed

Insights

Strain imaging offers a validated, robust method for assessing heart failure (HF) beyond traditional ejection fraction. This technique provides crucial insights into myocardial mechanics for risk prediction, diagnosis, and treatment monitoring in HF patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Traditional heart failure (HF) imaging relies on systolic and diastolic function, and left ventricular (LV) filling pressure.
  • Conventional markers like ejection fraction and E/e' have limitations, particularly for HF with preserved ejection fraction.
  • Strain imaging, a novel echocardiographic technique, offers a window into myocardial mechanics.

Purpose of the Study:

  • To review the evidence for myocardial strain imaging in various stages of heart failure.
  • To highlight the utility of LV global longitudinal strain and other strain parameters.
  • To demonstrate the role of strain imaging in risk prediction, diagnosis, treatment response assessment, and follow-up.

Main Methods:

  • Review of existing evidence on myocardial strain imaging in heart failure.
  • Focus on LV global longitudinal strain and other strain parameters.
  • Application across 9 distinct situations in HF management.

Main Results:

  • Myocardial strain imaging is well-validated and robust.
  • It can be readily implemented on modern echocardiography machines.
  • Strain parameters provide valuable information for HF assessment and risk stratification.

Conclusions:

  • Myocardial deformation imaging, specifically strain imaging, is evolving from a research tool to clinical practice.
  • It offers clinicians a valuable additional imaging parameter for HF assessment.
  • Strain imaging facilitates improved risk evaluation and patient management in heart failure.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
272